Trials / Completed
CompletedNCT04300738
Evaluation and Comparison of Two Biomarkers (VOP and SCC) for the Prognosis of the Occurrence of Clinical Cardiovascular Events
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 220 (actual)
- Sponsor
- Clinique Bizet · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of our study is to assess the Cardiovascular risk and the quality of the arteries by comparing the Coronary Calcium Score SCC measured with a CT scann and the Pulse Wave Velocity PWV measured with pOpmeter for the prognosis at 6 months of clinical events. Is there a superiority of PWV compared to SCC:
Detailed description
Two method of cardiovascular risk screening are compared in patient going for Coronary Calcium Score measurement in a outpatient clinic. Ct Scann is expensive, learning time is for at least 2 years, and the reliability is operator dependent. The Pulse Wave Velocity is measured using a new device with half an hour learning curve, and you get a result within 2 minutes. 1. A non-invasive medical device vs invasive 2. A better benefit-risk ratio 3. A lower diagnostic cost both for equipment and for qualification for use and learning time
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | CCS wit CT Scann measurement | Measurement with 2 devices |
Timeline
- Start date
- 2020-05-15
- Primary completion
- 2021-02-05
- Completion
- 2022-02-15
- First posted
- 2020-03-09
- Last updated
- 2022-03-09
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04300738. Inclusion in this directory is not an endorsement.